Sleep Apnea: Important Information for Patients Using Certain Respiratory Medical Devices from Philips Respironics
Global Respiratory Device Recall
On June 14, Philips Respironics conducted a voluntary safety recall of several models of devices used, among other things, for sleep apnea; either continuous positive pressure ventilation (CPAP), bilevel positive pressure ventilation (BiPAP) devices, as well as certain models of mechanical ventilators, the detailed list of which is available here.
In support of this recall, the company states that the affected devices may pose health risks related to noise-cancelling foam.
Recommendations for patients
In their recall, Philips Respironics asks patients using the recalled CPAP or BiPAP ventilation device to first stop using the device and then contact their physician to determine the most appropriate options for further action. of the treatment.
Due to the serious risks that may be associated with abrupt discontinuation of treatment in some patients, the Association des pneumologues de la province du Québec (APPQ) recommends that patients on CPAP or BiPAP not discontinue their treatment before discuss it with their doctor or respiratory therapist, when they are in one of the following situations :
- if they have severe breathing difficulties;
- if they had significant sleepiness during the day before the start of their treatment;
- if they have significant pulmonary, cardiovascular or neurological comorbidities;
- if they hold safety-critical positions (professional drivers, pilots, heavy machinery operators, etc.).
For any questions related to the continuation of treatment, patients are invited to contact their doctor or respiratory therapist to determine what to do in this unique situation.
It is also recommended that you stop using ozone-based cleaners and follow the device's user manual for approved cleaning methods.
Physicians and respiratory therapists mobilized
In order to ensure the protection of the public, the College of Physicians of Quebec (CMQ) and the Professional Order of Inhalotherapists of Quebec (OPIQ), in collaboration with the APPQ, sent a
notice to their members (doctors and respiratory therapists) concerning this recall and recommendations so that they can help inform and support their patients affected by this recall, given the data currently available.
The CMQ and the OPIQ, in collaboration with the APPQ, will continue to monitor this situation, call on the authorities concerned and inform their members and the public.
To know more